Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex
E M Wijsman, J D Brunzell, G P Jarvik, et al.
Neurology
|
June 20, 1998
Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
D Carmelli, G E Swan, T Reed, et al.
American Journal of Human Genetics
|
May 4, 2001
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression
V H Brophy, R L Jampsa, J B Clendenning, et al.
Pharmacogenetics
|
July 18, 2000
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype
V H Brophy, G P Jarvik, R J Richter, et al.
Pharmacogenetics
|
February 24, 2001
Polymorphisms in the human paraoxonase (PON1) promoter
V H Brophy, M D Hastings, J B Clendenning, et al.
American Journal of Human Genetics
|
July 1, 1997
Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis
G P Jarvik, E L Goode, M A Austin, et al.
Archives of Neurology
|
December 1, 1994
Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele
T Reed, D Carmelli, G E Swan, et al.
Journal of the National Cancer Institute. Monographs
|
June 16, 2000
Confirmation of prostate cancer susceptibility genes using high-risk families
G P Jarvik, J L Stanford, E L Goode, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2000
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype
G P Jarvik, L S Rozek, V H Brophy, et al.
Genetic Epidemiology
|
January 1, 1995
Analysis of quantitative risk factors for a common oligogenic disease
K A Goddard, G P Jarvik, J Graham, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex
E M Wijsman, J D Brunzell, G P Jarvik, et al.
Neurology
|
June 20, 1998
Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
D Carmelli, G E Swan, T Reed, et al.
American Journal of Human Genetics
|
May 4, 2001
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression
V H Brophy, R L Jampsa, J B Clendenning, et al.
Pharmacogenetics
|
July 18, 2000
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype
V H Brophy, G P Jarvik, R J Richter, et al.
Pharmacogenetics
|
February 24, 2001
Polymorphisms in the human paraoxonase (PON1) promoter
V H Brophy, M D Hastings, J B Clendenning, et al.
American Journal of Human Genetics
|
July 1, 1997
Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis
G P Jarvik, E L Goode, M A Austin, et al.
Archives of Neurology
|
December 1, 1994
Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele
T Reed, D Carmelli, G E Swan, et al.
Journal of the National Cancer Institute. Monographs
|
June 16, 2000
Confirmation of prostate cancer susceptibility genes using high-risk families
G P Jarvik, J L Stanford, E L Goode, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2000
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype
G P Jarvik, L S Rozek, V H Brophy, et al.
Genetic Epidemiology
|
January 1, 1995
Analysis of quantitative risk factors for a common oligogenic disease
K A Goddard, G P Jarvik, J Graham, et al.
Page
of 5